Andres Merits Selected Research

Chikungunya Fever

3/2021	1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.
1/2018	Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
12/2015	Correction for Chen et al., Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection.
6/2015	Antiviral activity of silymarin against chikungunya virus.
1/2015	Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.
11/2014	Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andres Merits Research Topics

Disease

46	Infections 01/2022 - 04/2007
13	Virus Diseases (Viral Diseases) 12/2021 - 01/2007
6	Chikungunya Fever 03/2021 - 11/2014
4	Neoplasms (Cancer) 06/2021 - 05/2011
4	Alphavirus Infections 01/2019 - 03/2011
4	Inflammation (Inflammations) 01/2017 - 03/2014
3	COVID-19 01/2022 - 01/2021
3	Zika Virus Infection 01/2020 - 11/2017
3	Bites and Stings (Sting) 01/2020 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 06/2021 - 03/2017
2	Communicable Diseases (Infectious Diseases) 01/2020 - 03/2014
2	Arthritis (Polyarthritis) 01/2019 - 01/2015
2	Arthralgia (Joint Pain) 01/2017 - 01/2017
1	Candidiasis (Moniliasis) 01/2022
1	Aspergillosis 01/2022
1	Glioma (Gliomas) 06/2021
1	Arbovirus Infections 01/2020
1	Multiple Myeloma 01/2020
1	Flavivirus Infections 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 03/2017
1	Neuroblastoma 03/2017
1	Edema (Dropsy) 01/2017
1	Necrosis 01/2017
1	Viremia 08/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013
1	Melanoma (Melanoma, Malignant) 01/2013

Drug/Important Bio-Agent (IBA)

24	Antiviral Agents (Antivirals)IBA 11/2021 - 03/2011
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2007
16	VaccinesIBA 04/2021 - 01/2014
6	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2013
5	Viral RNAIBA 12/2021 - 12/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
3	CytokinesIBA 01/2020 - 12/2012
3	Messenger RNA (mRNA)IBA 12/2018 - 12/2012
2	Viral ProteinsIBA 11/2021 - 01/2018
2	Peptide Hydrolases (Proteases)FDA Link 04/2021 - 12/2019
2	InterferonsIBA 04/2019 - 03/2017
2	Amino Acids FDA Link 04/2019 - 08/2015
2	MicroRNAs (MicroRNA)IBA 03/2017 - 01/2013
2	bindaritIBA 12/2015 - 01/2015
2	Monocyte Chemoattractant ProteinsIBA 12/2015 - 01/2015
1	SolutionsIBA 01/2022
1	posaconazole FDA Link 01/2022
1	Complex MixturesIBA 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 12/2021
1	tomatidineIBA 11/2021
1	Interferon Type IIBA 06/2021
1	Ribonuclease III (RNase III)IBA 01/2021
1	NucleosidesIBA 01/2021
1	remdesivirIBA 01/2021
1	Untranslated Regions (Untranslated Region)IBA 01/2021
1	ChloridesIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	RutheniumIBA 01/2020
1	SaltsIBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2019
1	IsotopesIBA 04/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	HydrolasesIBA 10/2018
1	baicalinIBA 01/2018
1	ElementsIBA 01/2018
1	LuciferasesIBA 11/2017
1	Biological ProductsIBA 11/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Explosive Agents (Explosives)IBA 01/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	BerberineIBA 11/2016
1	InflammasomesIBA 01/2016
1	PyrrolesIBA 12/2015
1	Glycoproteins (Glycoprotein)IBA 08/2015
1	AntigensIBA 11/2014
1	Attenuated VaccinesIBA 03/2014
1	AutoantibodiesIBA 03/2014
1	geldanamycinIBA 03/2014
1	Nucleoside-TriphosphataseIBA 02/2014
1	ProteomeIBA 09/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 09/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2013
1	LipofectamineIBA 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013

Therapy/Procedure

8	Therapeutics 06/2021 - 05/2011
2	Immunotherapy 06/2021 - 03/2017
2	Intravenous Injections 01/2020 - 03/2017
1	Oncolytic Virotherapy 06/2021